The latest on artificial intelligence transforming medicine

Insilico’s 3D Benchmark Warning Shows Drug Discovery AI Is Entering Its Accountability Era

Insilico Medicine says frontier AI models show important limitations on 3D drug discovery benchmarks, adding a note of caution to the sector’s rapid progress narrative. The announcement is notable because it shifts attention from capability marketing toward the harder question of where these models fail in chemically and biologically meaningful tasks.